A Phase 1, Randomised, Activator-Controlled, Double-Blind, Parallel Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Varicella zoster virus vaccine-EyeGene (Primary) ; AS01B; GSK 137173A
- Indications Herpes zoster
- Focus Adverse reactions; First in man
- Sponsors EyeGene
Most Recent Events
- 03 Feb 2021 Status changed from not yet recruiting to completed.
- 31 Dec 2019 New trial record